ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

(R)-α-リポ酸

Lipoic acid

HCID 6112
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
1200-22-2
標準SMILES
O=C(O)CCCC[C@@H]1CCSS1
InChIKey
AGBQKNBQESQNJD-SSDOTTSWSA-N
分子式
C8H14O2S2
平均分子量
206.3 g/mol
単同位体質量
206.04352203

概要

(R)-lipoic acid is the (R)-enantiomer of lipoic acid. A vitamin-like, C8 thia fatty acid with anti-oxidant properties. It has a role as a cofactor, a prosthetic group and a nutraceutical. It is a lipoic acid, a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a (R)-lipoate. It is an enantiomer of a (S)-lipoic acid.

名称と識別子

優先名称
Lipoic acid
IUPAC
5-[(3R)-dithiolan-3-yl]pentanoic acid
現地名
(R)-α-リポ酸
英語名
(R)-Lipoic acid
分子式
C8H14O2S2
分子量
206.33

名称と別名

lipoic acid(R)-lipoic acid(R)-5-(1,2-Dithiolan-3-yl)pentanoic acid(R)-alpha-Lipoic acidD-Thioctic acid(R)-(+)-1,2-Dithiolane-3-pentanoic acidR-(+)-Thioctic acid(+)-alpha-Lipoic acid1,2-Dithiolane-3-pentanoic acid, (3R)-R-alpha-Lipoic acidThioctic acid d-form5-[(3R)-dithiolan-3-yl]pentanoic acid
名称をさらに表示
(R)-α-リポ酸(R)-1,2-ジチオラン-3-ペンタン酸(R)-チオクト酸d-チオクト酸リポアランチオクト酸(R)-1,2-ジチオラン-3α-ペンタン酸リポ酸(R)-リポ酸α-リポ酸[R,(+)]-1,2-ジチオラン-3-ペンタン酸(R)-1,2-ジチオラン-3-吉草酸(R)-(+)-1,2-ジチオラン-3-ペンタン酸(R)-(+)-Α-リポ酸1,2-ジチオラン-3α-ペンタン酸5-[(3R)-1,2-ジチオラン-3-イル]ペンタン酸α-ジヒドロリポ酸ipoic acidTiobe(R)-(+)-α
ThiogammaLipoecTiobec5-[(3R)-1,2-dithiolan-3-yl]pentanoic acidR-Lipoic acid(R)-(+)-lipoic acid(R)-1,2-Dithiolane-3-pentanoic acid(R)-6,8-thioctic acid

物性

構造計算による物性

XLogP
1.7
極性表面積
87.9 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
5
重原子数
12
形式電荷
0
複雑度
150

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Thia fatty acids [FA0113]
SpringerMaterials PropertiesCrystal structure
SolubilityInsoluble
Melting Point60.5 °C
Physical DescriptionSolid

物理化学的性質

融点
48 · 48-52 °C(lit.)
沸点
185 · 185-195 °C(Press: 0.5 Torr)
比旋光度
23 · D23 +104° (c = 0.88 in benzene)
比重(密度)
1.218 · 1.218±0.06 g/cm3(Predicted)
屈折率
114 ° · 114 ° (C=1, EtOH)
闪点
230 °F · >230 °F
貯蔵温度
-20 °C · -20°C
溶解性
アセトニトリル(微量)、クロロホルム(微量)、DMSO
外見
個体

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

Treatment · 1 件

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 1 件

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.

化学と産業

薬理情報

Pharmacodynamics · 1 件

Lipoic acid (or α-lipoic acid) is able to pass the blood-brain barrier and is putatively used for detoxification of mercury attached to the brain cells. It can mobilise bound mercury into the blood stream as it is a mercaptan (sulfur compound which readily binds to the mercury). In the blood stream, another chelator such as dimercaptosuccinic acid (DMSA) or methylsulfonylmethane (MSM) is used to transfer mercury safely into the urine for excretion. Since DMSA cannot cross the blood-brain barrier, both lipoic acid and DMSA tend to be used together. It is hypothesized that this treatment-along with carnitine, dimethylglycine (DMG), Vitamin B6, folic acid, and magnesium—could be used to treat autism and amalgam poisoning. In this hypothesis, the reason why autism is difficult to treat is that mercury is attached to the brain cells and most medicines and vitamin supplements do not penetrate the blood-brain barrier. However, α-lipoic acid and perhaps vitamin B12 could making it possible for other chelators to remove mercury safely out of the body and could perhaps one day be used as a treatment for autism. Because lipoic acid is related to cellular uptake of glucose and it is both soluble in water and fat, it is being used for treatment in diabetes. It may be helpful for people with Alzheimer's disease or Parkinson's disease.

Mechanism of Action · 1 件

Lipoic Acid is generally involved in oxidative decarboxylations of keto acids and is presented as a growth factor for some organisms. Lipoic acid exists as two enantiomers, the R-enantiomer and the S-enantiomer. Normally only the R-enantiomer of an amino acid is biologically active, but for lipoic acid the S-enantiomer assists in the reduction of the R-enantiomer when a racemic mixture is given. Some recent studies have suggested that the S-enantiomer in fact has an inhibiting effect on the R-enantiomer, reducing its biological activity substantially and actually adding to oxidative stress rather than reducing it. Furthermore, the S-enantiomer has been found to reduce the expression of GLUT-4s in cells, responsible for glucose uptake, and hence reduce insulin sensitivity.

Metabolism/Metabolites · 1 件

Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of OP exposure.

関連反応

49 件
反応記録を作成
HRID 215663 の反応式
HRID 215663生成物として
HRID 395865 の反応式
HRID 395865反応物として
HRID 429699 の反応式
HRID 429699反応物として
HRID 520267 の反応式
HRID 520267反応物として
HRID 849563 の反応式
HRID 849563反応物として
HRID 869794 の反応式
HRID 869794反応物として
HRID 870284 の反応式
HRID 870284反応物として
HRID 896940 の反応式
HRID 896940生成物として
前へ1 / 7 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
1200-22-2、62-46-4
PubChem CID
6112
DTXSID
DTXSID20152651
ChEMBL
CHEMBL134342
ChEBI
CHEBI:30314
UNII
VLL71EBS9Z
Nikkaji
J9.331I
酸解離定数(Pka)
5.4 · 5.4(at 25℃)
色
薄黄色から黄色の低融点
Merck
14 · 14,9326
InChI
1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1
InChIKey
AGBQKNBQESQNJD-SSDOTTSWSA-N
SMILES
OC(=O)CCCC[C@@H]1CCSS1 || OC(=O)CCCC[C@@H]1CCSS1
LogP
2.16 · 2.160 (est)
CAS データベース
1200 · 1200-22-2(CAS DataBase Reference)

化学的性質

化学的特性Yellow Crystalline Solid

Toxicity Summary · 1 件

(R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.

Signs and Symptoms · 1 件

Symptoms of low dose exposure include excessive salivation and eye-watering. Acute dose symptoms include severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Hypertension, hypoglycemia, anxiety, headache, tremor and ataxia may also result.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

安全データ

wgk
3
hs_code
29349990
risk_code
22-36/38
化審法
(5)-535
safety_code
20-36-26-35
ストレージクラス
11 - Combustible Solids
Tissue LocationsKidney
Cellular LocationsCytoplasm
Metabolite Pathways3-Phosphoglycerate dehydrogenase deficiency

用途と製造

UsesFor nutritional supplementation, also for treating dietary shortage or imbalance.
応用分野 · 4 件

解説チオクト酸とは、化学式がC8H14O2S2の有機化合物です。 「リポ酸」「α-リポ酸」とも呼ばれています。光学活性を持ち、数多くの酵素の補助因子として必要な有機化合物です。 チオクト酸は、細胞のミトコンドリア内で働く補酵素の1種です。ミトコンドリア内で熱エネルギーの産生を高め、新陳代謝を促進すると言われており、抗酸化作用が非常に強く、ビタミンCなどの400倍とされています。抗酸化力に加え、糖代謝の促進や重金属排泄作用にも期待されています。

使用A fat-metabolism stimulator

一般的な説明α-Lipoic acid is an antioxidant which is generally present in plants, animals and many other microorganisms.

使用用途チオクト酸は、医薬品の原料として利用されています。通常成人はチオクト酸アミドとして10~60mgを1日に1~3回分割経口服用すると、肝機能障害の改善や脳代謝への作用が見られます。 以前は医薬品のみに利用されていましたが、2004年3月からはサプリメントにも利用されています。ニンジン、トマト、ホウレンソウ、ブロッコリー、レバーなどにもごく微量含まれ、人体でも生成可能です。

上流・下流製品情報

下流製品

6,8-ジメルカプトオクタン酸